AWM
SRNE

AE Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

AE Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,207
Closed -$11.7K – 2036
2022
Q4 		$11.7K Sell
13,207
-500
-4% -$663 ﹤0.01% 1794
2022
Q3 		$22K Buy
13,707
+32
+0.2% +$73 ﹤0.01% 1714
2022
Q2 		$27K Sell
13,675
-100
-0.7% -$173 ﹤0.01% 1695
2022
Q1 		$32K Buy
13,775
+1,219
+10% +$3.8K ﹤0.01% 1646
2021
Q4 		$58K Sell
12,556
-2,105
-14% -$13.1K ﹤0.01% 1656
2021
Q3 		$112K Buy
14,661
+2,126
+17% +$18K ﹤0.01% 1552
2021
Q2 		$121K Buy
+12,535
New +$99.8K ﹤0.01% 1525

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

AE Wealth Management's SRNE Position: Q1 2023 in Review

AE Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 13,207 shares — an estimated $11.7K sold.

AE Wealth Management first reported a position in SRNE in Q2 2021 and held it in 7 quarters. The position peaked at $121K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • AE Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • AE Wealth Management sold 13,207 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $11.7K.
  • AE Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2021 and held it in 7 quarters.
  • AE Wealth Management's Sorrento Therapeutics, Inc. position peaked at $121K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on AE Wealth Management's 13F filing for Q1 2023, filed 14 Apr 2023.